🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
University of Virginia Cancer Center
Start Date
2004-06
Trial ID
NCT00091273
RATIONALE: Vaccines made from peptides may help the body build an effective...
Status
Terminated
Location
University of Virginia Cancer Center
Start Date
2006-04-13
Trial ID
NCT00373217
RATIONALE: Vaccines made from peptides may help the body build an effective...
Status
Completed
Location
Fox Chase Cancer Center - Philadelphia
Start Date
2005-03
Trial ID
NCT00118274
RATIONALE: Vaccines made from a person's dendritic cells mixed with peptide...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2005-09
Trial ID
NCT00404339
RATIONALE: Vaccines may help the body build an effective immune response ag...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
1997-11
Trial ID
NCT00712634
Treatments Being Tested
The purpose of this study is to determine the good and bad effects of atezo...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2019-05-08
Trial ID
NCT03359239
Treatments Being Tested
The goals of this study are to evaluate 1) the safety of administration of ...
Status
Terminated
Location
University of Virginia
Start Date
2009-11
Trial ID
NCT00977145
Treatments Being Tested
RATIONALE: Vaccines made from peptides may help the body build an effective...
Status
Completed
Location
University of Virginia Cancer Center
Start Date
2004-11-04
Trial ID
NCT00118313
This is an open-label, phase II study of a vaccine comprising melanoma pept...
Status
Completed
Location
University of Virginia
Start Date
2000-08
Trial ID
NCT00938223
Treatments Being Tested
The purpose of this study is to evaluate T cell responses against a peptide...
Status
Completed
Location
University of Virginia Health System
Start Date
2009-05
Trial ID
NCT00892567
Treatments Being Tested